✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Themis Medicare Ltd.

THEMISMED

Market Cap
₹1,223 Cr.
P/E
40.99

Themis Medicare Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
1,223 Cr
PE
PE
40.99
Prom Holding
Prom Holding
67.15 %
ROE (%)
ROE (%)
11.52
ROCE (%)
ROCE (%)
10.69
Div Yield (%)
Div Yield (%)
0.38
Sales
Sales
405 Cr
OPM (%)
OPM (%)
12.10 %
Debt to Equity
Debt to Equity
0.25
View more
Edit Ratio's
About
Themis Medicare Ltd. is a research-based pharmaceutical company specializing in manufacture of… Read more
Low
115
52W Range
High
317
  • Themis Medicare
  • Hester Biosciences
  • Kopran
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Verticals

Operational Metrics

    locked
    Select a Metric
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Themis Medicare Ltd. Business

    Themis Medicare Ltd. is a research-based pharmaceutical company focusing on Pain Management, Critical Care, and Anti-Infectives. It develops differentiated products for patient benefit.

    Themis Medicare major competitors are Hester Biosciences, Kopran, Bajaj Healthcare, Shree Ganesh Remed., NGL Fine-Chem, Nectar Lifesciences, SMS Pharmaceuticals.
    Market Cap of Themis Medicare is ₹1,223 Crs.
    While the median market cap of its peers are ₹887 Crs.

    Themis Medicare seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice
    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Sep Sep Dec
    Investor Presentation May Mar Jun Sep Dec Mar Jun Sep Dec Sep Dec
    Conference Call Mar Sep Sep Dec
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Themis Medicare Ltd.
    Interview With Dr Sachin Patel, CEO, Themis Medicare and Gujarat Themis Biosyn - Sensei Kujaku
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material